News/ News/ R&D CAMP4 raises $100m to take lead RNA drugs into clinic Phil Taylor antisense oligonucleotides, CAMP4 Therapeutics, financing, rna 0 Comment Armed with a $100 million second-round financing, CAMP4 Therapeutics is preparing to start the first clinical trial of Share X CAMP4 raises $100m to take lead RNA drugs into clinic https://pharmaphorum.com/news/camp4-raises-100m-to-take-lead-rna-drugs-into-clinic/
antisense oligonucleotides, CAMP4 Therapeutics, financing, rna
0 Comment
